Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

First Wave BioPharma Inc. (FWBI)

  • Technical Exchange News
  • May 17, 2024, 00:18 UTC
  • 38
  • 0 comments

NASDAQ traded attribute type Test_mode was changed. Previous value: N. New value: First Wave BioPharma, Inc. - Common Stock.

Comment Full text

Intensity Therapeutics Inc (INTS)

  • Technical Exchange News
  • May 16, 2024, 18:39 UTC
  • 45
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Palisade Bio Inc. (PALI)

  • Technical Exchange News
  • May 16, 2024, 01:38 UTC
  • 38
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

iCoreConnect Inc (ICCT)

  • Technical Exchange News
  • May 16, 2024, 01:38 UTC
  • 42
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Palisade Bio Inc. (PALI)

  • Technical Exchange News
  • May 15, 2024, 18:54 UTC
  • 40
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

iCoreConnect Inc (ICCT)

  • Technical Exchange News
  • May 15, 2024, 18:53 UTC
  • 39
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Evaxion Biotech A/S (EVAX)

  • Technical Exchange News
  • May 15, 2024, 01:52 UTC
  • 40
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Cidara Therapeutics Inc. (CDTX)

  • Technical Exchange News
  • May 15, 2024, 01:52 UTC
  • 39
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient and Delinquent. New value: Normal.

Comment Full text

Biomerica Inc. (BMRA)

  • Technical Exchange News
  • May 15, 2024, 01:52 UTC
  • 39
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Evaxion Biotech A/S (EVAX)

  • Technical Exchange News
  • May 14, 2024, 18:57 UTC
  • 40
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text
  • Previous
  • 957
  • 958
  • 959
  • 960
  • 961
  • Next

Search

News categories

  • Technical Exchange News(14591)
  • Event(6229)
  • SEC News(384260)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(235026)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin